MabVax Therapeutics Holdings, Inc. (MBVXQ) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
11535 SORRENTO VALLEY ROAD SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 594 | 1,056 | 886 | 3,053 | 1,847 | 597 | |||
| Cash and cash equivalents | 594 | 1,056 | 886 | 3,053 | 1,847 | 597 | |||
| Prepaid expense | 31 | 139 | 150 | 304 | 61 | 199 | |||
| Other current assets | 143 | 153 | 171 | 118 | 89 | 10 | |||
| Total current assets: | 768 | 1,348 | 1,208 | 3,475 | 1,997 | 806 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 498 | 538 | 578 | 619 | 664 | 686 | |||
| Intangible assets, net (including goodwill) | 6,826 | 6,826 | 6,826 | 6,826 | 6,826 | 6,826 | |||
| Goodwill | 6,826 | 6,826 | 6,826 | 6,826 | 6,826 | 6,826 | |||
| Other noncurrent assets | 179 | 179 | 179 | 179 | 169 | 337 | |||
| Other undisclosed noncurrent assets | 0 | ||||||||
| Total noncurrent assets: | 7,502 | 7,543 | 7,583 | 7,624 | 7,659 | 7,850 | |||
| TOTAL ASSETS: | 8,271 | 8,890 | 8,790 | 11,099 | 9,655 | 8,655 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,987 | 3,934 | 3,111 | 3,837 | 4,415 | 4,076 | |||
| Interest and dividends payable | 72 | 36 | 39 | 42 | 46 | 51 | |||
| Employee-related liabilities | 343 | 393 | 312 | 742 | 639 | 704 | |||
| Accounts payable | 1,979 | 1,102 | 1,091 | 1,550 | 2,087 | 1,724 | |||
| Accrued liabilities | 2,593 | 2,404 | 1,669 | 1,503 | 1,643 | 1,597 | |||
| Debt | 1,685 | 2,542 | 1,700 | 1,711 | 1,684 | 1,684 | |||
| Other undisclosed current liabilities | 1,056 | 69 | 995 | 846 | 958 | 994 | |||
| Total current liabilities: | 7,729 | 6,545 | 5,806 | 6,393 | 7,057 | 6,754 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 912 | 1,318 | 1,667 | 2,008 | 2,344 | 2,667 | |||
| Long-term debt, excluding current maturities | 876 | 1,276 | 1,621 | 1,958 | 2,285 | 2,603 | |||
| Capital lease obligations | 36 | 41 | 46 | 50 | 59 | 64 | |||
| Liabilities, other than long-term debt | 197 | 194 | 186 | 177 | 167 | 157 | |||
| Other liabilities | 197 | 194 | 186 | 177 | 167 | 157 | |||
| Total noncurrent liabilities: | 1,109 | 1,512 | 1,854 | 2,185 | 2,511 | 2,824 | |||
| Other undisclosed liabilities | 1 | ||||||||
| Total liabilities: | 8,838 | 8,056 | 7,660 | 8,578 | 9,568 | 9,578 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (567) | 834 | 1,130 | 2,520 | 87 | (923) | |||
| Common stock | 93 | 90 | 69 | 189 | 92 | 63 | |||
| Additional paid in capital | 118,023 | 115,410 | 112,105 | 103,349 | 94,803 | 82,623 | |||
| Accumulated deficit | (118,691) | (114,674) | (111,054) | (101,047) | (94,846) | (83,617) | |||
| Other undisclosed equity, attributable to parent | 9 | 8 | 10 | 29 | 38 | 8 | |||
| Other undisclosed equity | (1) | ||||||||
| Total equity: | (567) | 834 | 1,130 | 2,520 | 87 | (923) | |||
| TOTAL LIABILITIES AND EQUITY: | 8,271 | 8,890 | 8,790 | 11,099 | 9,655 | 8,655 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 700 | |||||||
| Cost of revenue | ||||||||
| Gross profit: | 700 | |||||||
| Operating expenses | (3,170) | (3,435) | (4,389) | (2,849) | (5,741) | (5,092) | ||
| Operating income (loss): | (2,470) | (3,435) | (4,389) | (2,849) | (5,741) | (5,092) | ||
| Nonoperating expense (Other Nonoperating expense) | (158) | (186) | (207) | (231) | (249) | (263) | ||
| Interest and debt expense | (102) | (483) | (139) | (151) | (157) | |||
| Income (loss) from continuing operations: | (2,730) | (3,621) | (5,079) | (3,219) | (6,141) | (5,512) | ||
| Income (loss) before gain (loss) on sale of properties: | (2,730) | (3,621) | (5,079) | (3,219) | (6,141) | (5,512) | ||
| Net income (loss): | (2,730) | (3,621) | (5,079) | (3,219) | (6,141) | (5,512) | ||
| Other undisclosed net income attributable to parent | 102 | 483 | 139 | 151 | 157 | |||
| Net income (loss) attributable to parent: | (2,628) | (3,621) | (4,596) | (3,080) | (5,990) | (5,355) | ||
| Other undisclosed net loss available to common stockholders, basic | (1,388) | (5,411) | (3,120) | (5,239) | ||||
| Net income (loss) available to common stockholders, diluted: | (4,016) | (3,621) | (10,007) | (6,200) | (11,229) | (5,355) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,730) | (3,621) | (5,079) | (3,219) | (6,141) | (5,512) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,730) | (3,621) | (5,079) | (3,219) | (6,141) | (5,512) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.